VMP 33745311000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Saxagliptin 5mg / Dapagliflozin 10mg tablets
BNF code 0601023AVAAAAAA
Virtual Therapeutic Moiety Saxagliptin + Dapagliflozin
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Dapagliflozin propanediol monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 703674001
Strength value numerator 10.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Saxagliptin hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 443087004
Strength value numerator 5.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd)
Virtual Medicinal Product Packs
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback